GANX
#4129
Gain Therapeutics, Inc. - Common Stock
1.7 6 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.22%
Monthly Change
+2.92%
6 month change
-20.00%
Year Change
-5.38%
Previous Close
1.8 0
Open
1.7 6
Low
1.7 6
High
1.7 6
Volume
8
Financials
- Market Capitalization 75.07 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.gaintherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00W7D7CJ9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.28
Price to sales ratio
-127.34
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4106 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.63 USD | -8.70% | -22.22% | -21.25% | +28.57% | 78.05 M USD | ||
| 4108 |  RNTX Rein Therapeutics, Inc. - Common Stock | 0.91 USD | -7.14% | -11.65% | -4.21% | -17.30% | 77.84 M USD | ||
| 4152 |  IBIO iBio, Inc. - Common Stock | 1.45 USD | -3.97% | -12.12% | -15.20% | -36.96% | 72.03 M USD | ||
| 4155 |  XBIT XBiotech Inc. - Common Stock | 2.33 USD | +1.75% | -2.10% | -1.69% | -19.66% | 71.04 M USD |
Frequently asked questions about Gain Therapeutics, Inc. - Common Stock
What is the Gain Therapeutics, Inc. - Common Stock stock price today?
The current price of Gain Therapeutics, Inc. - Common Stock (GANX) is 1.76. Over the past 24 hours, the stock has changed by -2.22%. Follow the GANX chart for real-time price dynamics.
What is the stock ticker of Gain Therapeutics, Inc. - Common Stock?
Gain Therapeutics, Inc. - Common Stock trades under the ticker GANX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Gain Therapeutics, Inc. - Common Stock stock going up?
GANX has changed by -2.76% over the last week, +2.92% over the last month, and -5.38% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Gain Therapeutics, Inc. - Common Stock net income for the last quarter?
Gain Therapeutics, Inc. - Common Stock reported net income of -5.61 M for the last quarter. The previous quarter showed -4.54 M, which means net income changed by -23.61%.
How many employees does Gain Therapeutics, Inc. - Common Stock have?
As of the latest available data, Gain Therapeutics, Inc. - Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
What is Gain Therapeutics, Inc. - Common Stock EBITDA?
Gain Therapeutics, Inc. - Common Stock EBITDA is -5.5 M, and its EBITDA margin is 3 328.28%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Gain Therapeutics, Inc. - Common Stock stock?
You can buy Gain Therapeutics, Inc. - Common Stock (GANX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Gain Therapeutics, Inc. - Common Stock stock?
Investing in Gain Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GANX chart and related analysis on metatrader.com as part of your research.